Groups for XXX Poster Walkthroughs
GRASP brings scientists and patient advocates together for a personalized discussion about a scientific poster. Less like a presentation, and more like a conversation, advocates are encouraged to share their experiences as people living with or caring for someone with this disease.
Below are the group pages for REGISTERED attendees. For scientists or poster authors, please contact grasp@graspcancer.org to register. For others, please register at our ADVOCATE REGISTRATION
You can check your member dashboard to see the group(s) for which you registered
*PLEASE CHECK BACK CLOSER TO THE EVENT FOR YOUR ASSIGNED GROUPS AND POSTERS
WEDNESDAY, JUNE 14
10:00 AM – 11:30 AM EASTERN TIME (US/NEW YORK)
Group 1A: HER2+ BREAST CANCER; SYMPTOMS & SURVIVORSHIP
Mentor: Joan Mancuso
Scientist: Jenni Sheng, M.D.
Group 1B: HR+ BREAST CANCER; CLINICAL TRIALS; HORMONE THERAPIES
Mentor: Teresa Shipp
Scientist: Matteo Lambertini, M.D., Ph.D.
Group 1C: TRIPLE NEGATIVE BREAST CANCER; CLINICAL TRIALS; IMMUNOTHERAPY; TARGETED THERAPIES
Mentor: Debbie Denardi
Scientist: Myrto Moutafi, M.D.
Group 1D: BREAST & PAN-CANCERS; BRAIN METASTASIS; TUMOR BIOLOGY
Mentor: Martha Carlson
Scientist: Franziska Linke, Ph.D.
Poster Author: Gaia Griguolo, M.D.
Group 1E: PAN-CANCERS; HEALTHCARE EQUITY; SYMPTOMS & SURVIVORSHIP; UNDERSERVED POPULATIONS
Mentor: Caroline Johnson
Scientist: Tarah Ballinger, M.D.
Group 1F: PAN-CANCERS; CLINICAL TRIALS; SYMPTOMS & SURVIVORSHIP
Mentor: Christine Hodgdon
Scientist: Mingxiao Yang, Ph.D.
WEDNESDAY, JUNE 14
2:00 PM – 3:30 PM EASTERN TIME (US/NEW YORK)
Group 2A: HER2+ BREAST CANCER; BIOMARKERS; REAL-WORLD DATA/OUTCOMES; TUMOR BIOLOGY
Mentor: TBD
Scientist: Avni Bhalgat, Ph.D. Candidate
Group 2B: LOBULAR BREAST CANCER
Mentor: Julia Levine
Scientist: Steffi Oesterreich, Ph.D.
Group 2C: BREAST CANCER; BIOMARKERS; TUMOR BIOLOGY
Mentor: Joan Mancuso
Scientist: Eliza Barragan, Ph.D.
Group 2D: BREAST CANCER; CLINICAL TRIALS; SYMPTOMS & SURVIVORSHIP
Mentor: Amy Beumer
Scientist: Jasmine Sukumar, M.D.
Group 2E: BREAST & PAN-CANCERS; SYMPTOMS & SURVIVORSHIP; UNDERSERVED POPULATIONS
Mentor: Katie Edick
Scientist: Claire Conley, Ph.D.
Poster Author: Fionán Donohoe, M.D.
Group 2F: HR+ BREAST CANCER; CLINICAL TRIALS; NOVEL TARGETS & THERAPIES; TREATMENT RESISTANCE
Mentor: Teresa Shipp
Scientist: Vinton Cheng, M.D., Ph.D.
Group 2G: PAN-CANCERS; CLINICAL TRIALS; SYMPTOMS & SURVIVORSHIP
Mentor: Abigail Johnston, Esq
Scientist: Mingxiao Yang, Ph.D.
WEDNESDAY, JUNE 14
6:00 PM – 7:30 PM EASTERN TIME (US/NEW YORK)
Group 3A: HER2+ BREAST CANCER; BIOMARKERS
Mentor: Yvonne McLean Florence
Scientist: Sailajah Gukathasan, Ph.D.
Group 3B: HER2-LOW BREAST CANCER; BIOMARKERS
Mentor: Debbie Denardi
Scientist: Erin Howe, Ph.D.
Poster Author: Chiara Molinelli, M.D.
Group 3C: HR+ BREAST CANCER; IMAGING; IMMUNOTHERAPY
Mentor: Katie Edick
Scientist: Jessi Hersh, Ph.D.
Group 3D: HR+ BREAST & PAN-CANCERS; SEXUAL HEALTH; SYMPTOMS & SURVIVORSHIP
Mentor: Marlena Murphy
Scientist: Marielle Gross, M.D.
Group 3E: TRIPLE NEGATIVE BREAST CANCER; HEALTHCARE EQUITY; SYMPTOMS & SURVIVORSHIP; UNDERSERVED POPULATIONS
Mentor: Jasmine Souers
Scientist: Julia Falco, Ph.D. Candidate
THURSDAY, JUNE 15
10:00 AM – 11:30 AM EASTERN TIME (US/NEW YORK)
Group 4A: HER2+ BREAST CANCER; ANTIBODY-DRUG CONJUGATES; BRAIN METASTASIS; CLINICAL TRIALS; NOVEL TARGETS & THERAPIES
Mentor: TBD
Scientist: Guilherme Nader Marta, M.D.
Group 4B: HER2-LOW & HER2-ZERO BREAST CANCER; BRAIN METASTASIS; UNDERSERVED POPULATIONS
Mentor: Joan Mancuso
Scientist: Dionisia Quiroga, Ph.D.
Group 4C: HR+ BREAST CANCER; BIOMARKERS; CLINICAL TRIALS; TARGETED THERAPIES
Mentor: Ellen Landsberger, M.D.
Scientist: Aileen Fernandez, Ph.D.
Group 4D: INFLAMMATORY & TRIPLE NEGATIVE BREAST CANCER; BIOMARKERS; CLINICAL TRIALS; IMMUNOTHERAPY
Mentor: Ginny Mason, R.N.
Scientist: Larisa Gearhart-Serna, Ph.D.
Group 4E: PAN-CANCERS; SYMPTOMS & SURVIVORSHIP
Mentor: Marlena Murphy
Scientist: Shoshana Rosenberg, ScD, MPH
Group 4F: HER2+ & TRIPLE NEGATIVE BREAST CANCER; BRAIN METASTASIS; CLINICAL TRIALS; IMMUNOTHERAPY
Mentor: Marina Ivanovskaya
Scientist: Selena Lorrey, Ph.D. Candidate
Group 4G: HR+ BREAST CANCER; HORMONE THERAPIES; REAL-WORLD DATA/OUTCOMES; TARGETED THERAPIES
Mentor: TBD
Scientist: Stephanie Graff, M.D.
THURSDAY, JUNE 15
2:00 PM – 3:30 PM EASTERN TIME (US/NEW YORK)
Group 5A: HER2+ BREAST & PAN-CANCERS; CLINICAL TRIALS; IMMUNOTHERAPY; NOVEL TARGETS & THERAPIES
Mentor: Katie Edick
Scientist: Veronique Debien, M.D.
Group 5B: HER2-LOW & HER2-NEGATIVE BREAST CANCER; TARGETED THERAPIES
Mentor: Marlena Murphy
Scientist: Isaac Chan, M.D., Ph.D.
Group 5C: HR+ BREAST CANCER; CLINICAL TRIALS; NOVEL TARGETS & THERAPIES; TREATMENT RESISTANCE
Mentor: Julia Levine
Scientist: Erika Hamilton, M.D.
Group 5D: TRIPLE NEGATIVE & PAN-CANCERS; IMMUNOTHERAPY; REAL-WORLD DATA/OUTCOMES; TREATMENT RESISTANCE
Mentor: Samantha Horn
Scientist: Amanda Jacobson, Ph.D.
Group 5E: BREAST CANCER; BIOMARKERS; TUMOR BIOLOGY
Mentor: Victoria Goldberg
Scientist: Eliza Barragan, Ph.D.
Group 5F: HR+ BREAST CANCER; CLINICAL TRIALS; HORMONE THERAPIES; TARGETED THERAPIES; TREATMENT RESISTANCE
Mentor: Stephanie Walker, R.N.
Scientist: Vinton Cheng, M.D., Ph.D.
THURSDAY, JUNE 15
6:00 PM – 7:30 PM EASTERN TIME (US/NEW YORK)
Group 6A: HER2+ PAN-CANCERS; CLINICAL TRIALS; NOVEL TARGETS & THERAPIES
Mentor: Christine Hodgdon
Scientist: Sailajah Gukathasan, Ph.D.
Group 6B: HR+ BREAST CANCER; CLINICAL TRIALS; SYMPTOMS & SURVIVORSHIP
Mentor: Barbara Segarra-Vazquez
Scientist: Shoshana Rosenberg, ScD, MPH
Poster Author: Nathalie Levasseur, M.D.
Group 6C: TRIPLE NEGATIVE BREAST CANCER; BRAIN METASTASIS; CLINICAL TRIALS; NOVEL TARGETS & THERAPIES
Mentor: Abigail Johnston, Esq
Scientist: Jamie Spangler, Ph.D.
Group 6E: BREAST & PAN-CANCERS; LEPTOMENINGEAL DISEASE; CLINICAL TRIALS
Mentor: Joan Mancuso
Scientist: Laura Huppert, M.D.
Group 6F: BREAST & PAN-CANCERS; ANTIBODY-DRUG CONJUGATES; CLINICAL TRIALS
Mentor: Debbie Denardi
Scientist: Erin Howe, Ph.D.
Thank you to our sponsors
